Vimarsana
Biggest News Aggregation in the World

Brent Ness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brent Ness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brent Ness Today - Breaking & Trending Today

Better Data Better Care OCTOBER 2023 NASDAQ: ACON - Form 8-K -September 28, 2023 at 07:52 am EDT - Vimarsana News

Better Data Better Care OCTOBER 2023 NASDAQ: ACON - Form 8-K -September 28, 2023 at 07:52 am EDT

Expansion $135B 3 U.S. low back & neck pain market - ultimate market Market Opportunity 1 Martin BI, Spine Mar 1;44:369 - 376. 2 Kim LH, JAMA Network Open 2 3 Dieleman JL, JAMA 323 4 Ravindra VM,...

Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts - Vimarsana News

Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts

19.05.2023 - Up to $2M Unsecured, Non-Convertible Bridge Debt With No Required Amortization Payments Financing Supports Execution of the 2023 Plan and the Achievement of Critical Milestones in Support of Definitive Growth Capital BROOMFIELD, CO, May 19, ... Seite 1

Related Topics:
Aclarion NociscanBrent Ness
Aclarion to Host Thought Leadership Symposium at SPINEWEEK - Vimarsana News

Aclarion to Host Thought Leadership Symposium at SPINEWEEK

Nociscan™ is the first evidence-supported SaaS platform to objectively measure discogenic biomarkers for insight into pathological low back pain. Nociscan...

Dr. Christopher Ames to Join Aclarion as a Key Opinion - Vimarsana News

Dr. Christopher Ames to Join Aclarion as a Key Opinion

Broomfield, CO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare...

Aclarion's Key Opinion Leader Program Adds Fifth Surgeon - Vimarsana News

Aclarion's Key Opinion Leader Program Adds Fifth Surgeon

Development of this program supports Aclarion’s commitment to lead with strong clinical evidence and engage the payer community through key opinion...